Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
7.25
-0.14 (-1.89%)
May 8, 2026, 1:46 PM EDT - Market open
Clene Revenue
In the year 2025, Clene had annual revenue of $200.00K, down -41.52%. Clene had revenue of $77.00K in the quarter ending December 31, 2025, a decrease of -15.38%.
Revenue (ttm)
$200.00K
Revenue Growth
-41.52%
P/S Ratio
435.21
Revenue / Employee
$2,532
Employees
79
Market Cap
85.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 200.00K | -142.00K | -41.52% |
| Dec 31, 2024 | 342.00K | -312.00K | -47.71% |
| Dec 31, 2023 | 654.00K | 181.00K | 38.27% |
| Dec 31, 2022 | 473.00K | -250.00K | -34.58% |
| Dec 31, 2021 | 723.00K | 517.00K | 250.97% |
| Dec 31, 2020 | 206.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Hain Celestial Group | 1.51B |
| Bridgford Foods | 233.75M |
| Above Food Ingredients | 213.45M |
| LifeVantage | 195.32M |
| FitLife Brands | 81.46M |
| Laird Superfood | 49.89M |
| DDC Enterprise | 39.18M |
| BioHarvest Sciences | 34.51M |
CLNN News
- 6 hours ago - Clene price target raised to $50 from $48 at Canaccord - TheFly
- 1 day ago - Clene Transcript: Emerging Growth Conference 92 - Transcripts
- 3 days ago - Clene Announces $7 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 3 days ago - Clene to Present at Upcoming May Conferences - GlobeNewsWire
- 4 days ago - Clene provides update on NDA for ALS following Type C meeting with FDA - TheFly
- 4 days ago - After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS - GlobeNewsWire
- 2 months ago - Clene reports FY25 EPS ($2.65), consensus ($2.35) - TheFly
- 2 months ago - Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire